PTP GenAI Document Intelligence for Biotech
PTP · Intelligence & Research
Certification per AWS Marketplace.
Evidence tier Source Confirmed · 4 captures on record
What the publisher says
As described on AWS Marketplace.
PTP’s GenAI Document Intelligence for Biotech accelerates IND submissions, GxP compliance, and research paper processing by combining Amazon Bedrock with AWS-native services. The solution reduces manual review effort by 50%+, shortens regulatory timelines, and ensures HIPAA/GxP compliance—positioning AWS as the secure platform of choice for biotech document workflows.
Highlights
Highlighted by the publisher on AWS Marketplace.
By combining Amazon Bedrock with AWS-native data services, the solution delivers regulator-ready summaries, structured drafts, and intelligent search—reducing manual review effort while ensuring compliance and security.
The solution reduces manual review effort by 50%+, shortens regulatory timelines, and ensures HIPAA/GxP compliance
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Sources
Linked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.

